Cars.com
CARS
Hutchmed (China)
HCM
New Fortress Energy
NFE
Dorian LPG
LPG
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 8.260
- -0.010-0.12%
Trading Mar 11 10:10 ET
302.12MMarket Cap-4.21P/E (TTM)
8.590High8.060Low25.32KVolume8.270Open8.270Pre Close211.24KTurnover0.17%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High0.94P/B122.49MFloat Cap6.43052wk Low--Dividend TTM14.83MShs Float29.740Historical High--Div YieldTTM6.41%Amplitude6.430Historical Low8.343Avg Price1Lot Size
Rapport Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 126.27%21.64M | 213.73%20.8M | 229.30%17.09M | 36.18M | 14.79M | 9.56M | 6.63M | 5.19M |
| Selling and administrative expenses | 207.31%6.1M | 167.73%5.11M | 255.26%4.59M | --8.18M | --3M | --1.98M | --1.91M | --1.29M |
| -General and administrative expense | 207.31%6.1M | 167.73%5.11M | 255.26%4.59M | --8.18M | --3M | --1.98M | --1.91M | --1.29M |
| Research and development costs | 105.05%15.54M | 232.32%15.69M | 220.70%12.5M | --28M | --11.8M | --7.58M | --4.72M | --3.9M |
| Operating profit | -126.27%-21.64M | -213.73%-20.8M | -229.30%-17.09M | -36.18M | -14.79M | -9.56M | -6.63M | -5.19M |
| Net non-operating interest income expense | 379.32%4.1M | 1,112.22%2.68M | 2,320.00%1.82M | 2.53M | 1.38M | 856K | 221K | 75K |
| Non-operating interest income | 379.32%4.1M | 1,112.22%2.68M | 2,320.00%1.82M | --2.53M | --1.38M | --856K | --221K | --75K |
| Non-operating interest expense | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expense) | -617.48%-7.39M | -1.12M | -94K | -1.03M | ||||
| Other non- operating income (expenses) | ---- | ---- | -617.48%-7.39M | ---1.12M | ---94K | ---- | ---- | ---1.03M |
| Income before tax | -101.39%-17.54M | -182.74%-18.12M | -268.84%-22.67M | -34.78M | -13.51M | -8.71M | -6.41M | -6.15M |
| Income tax | 0 | 0 | 0 | 10K | 6K | 1K | 2K | 1K |
| Net income | -101.37%-17.54M | -182.65%-18.12M | -268.78%-22.67M | -34.79M | -13.52M | -8.71M | -6.41M | -6.15M |
| Net income continuous Operations | -101.37%-17.54M | -182.65%-18.12M | -268.78%-22.67M | ---34.79M | ---13.52M | ---8.71M | ---6.41M | ---6.15M |
| Minority interest income | ||||||||
| Net income attributable to the parent company | -101.37%-17.54M | -182.65%-18.12M | -268.78%-22.67M | -34.79M | -13.52M | -8.71M | -6.41M | -6.15M |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | -101.37%-17.54M | -182.65%-18.12M | -268.78%-22.67M | -34.79M | -13.52M | -8.71M | -6.41M | -6.15M |
| Basic earnings per share | -38.90%-0.5 | -541.54%-1.7 | -269.97%-0.94 | -1.47 | -0.3821 | -0.36 | -0.265 | -0.2541 |
| Diluted earnings per share | -38.90%-0.5 | -541.54%-1.7 | -269.97%-0.94 | -1.47 | -0.3821 | -0.36 | -0.265 | -0.2541 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |